Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to the study content, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedLocations section updated: Colorado, Massachusetts, New York, North Dakota, Ohio, South Dakota, and Texas are listed; corresponding state location entries were removed. Revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check60 days agoChange DetectedThe Publications section wording was updated to state that publications are automatically filled in from PubMed and may not be about the study, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding status notice banner was removed from the page. The study details and navigation remained unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedThe two screenshots show only layout and visual styling differences; no changes to core study information, eligibility criteria, endpoints, or enrollment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check109 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference2%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.